Trastuzumab Suspended Phase 2 Trials for Colorectal Cancers Treatment

IndicationsStatusPurposePhase
SuspendedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02291289A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)